Minaris Adds Dedicated Viral Vectors Business Unit, Splitting Into Three Specialized Divisions | BioBuzz
Minaris, the Philadelphia-based global cell and gene therapy CDMO and multimodal contract testing organization, announced on September 29, 2026 the addition…

What's Your Reaction?









